Subscriber access provided by UNIV OF CAMBRIDGE
Bioactive Constituents, Metabolites, and Functions
Proteomics Study Reveals That Docosahexaenoic and Arachidonic Acids Exert Different in Vitro Anticancer Activities in Colorectal Cancer Cells Ignacio Ortea, Maria Jose Gonzalez-Fernandez, Rebeca P Ramos-Bueno, and Jose Luis Guil Guerrero J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.8b00915 • Publication Date (Web): 26 May 2018 Downloaded from http://pubs.acs.org on May 26, 2018
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 36
Journal of Agricultural and Food Chemistry
1 2
Proteomics Study Reveals That Docosahexaenoic and
3 4
Arachidonic Acids Exert Different in Vitro Anticancer Activities
5
in Colorectal Cancer Cells
6 7
Ignacio Orteaa*, María José González-Fernándezb, Rebeca P. Ramos-Buenob,
8
and José Luis Guil-Guerrerob
9
a
IMIBIC, Hospital Universitario Reina Sofía, Universidad de Córdoba, E14004, Córdoba,
10
Spain. b
11 12
Food Technology Division, Agrifood Campus of International Excellence, ceiA3, University of Almería, E40120, Almería, Spain
13 14
* Corresponding author,
[email protected]; Phone +34 957 213 757
15 16
1
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
17 18
ABSTRACT Two PUFAs, DHA and ARA, as well as derivatives such as eicosanoids, regulate
19
different activities, affecting transcription factors and therefore DNA transcription, being a
20
critical step for the functioning of FA-derived signalling. This work has attempted to
21
determine the in vitro anticancer activities of these molecules linked to the gene
22
transcription regulation of HT-29 colorectal cancer cells. We applied 3-(4,5-
23
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test along with lactate-
24
dehydrogenase (LDH) and caspase-3 assays; proteome changes were assessed by
25
‘sequential windowed acquisition of all theoretical mass spectra’ (SWATH-MS)
26
quantitative proteomics followed by pathway analysis in order to determine the affected
27
molecular mechanisms. In all assays, DHA inhibited cell proliferation of HT-29 cells to a
28
higher extent than ARA and acted primarily by down-regulating proteasome particles,
29
while ARA presented a dramatic effect on all six DNA replication helicase particles. The
30
results indicated that both DHA and ARA are potential chemopreventive agent candidates.
31 32 33
KEY WORDS ARA; colorectal cancer; DHA; proteomics; PUFA; SWATH
34
2
ACS Paragon Plus Environment
Page 2 of 36
Page 3 of 36
35 36
Journal of Agricultural and Food Chemistry
INTRODUCTION Colorectal cancer (CRC) has one of the highest mortality rates. The fact that large
37
regional differences exist in the incidence and mortality of CRC suggests a close
38
relationship between genetic and environmental factors, with diet and lifestyle being two of
39
the most determinant for CRC incidence. Diet is widely recognised as a critical factor for
40
cancer risk and mortality.1
41
Free fatty acids (FFAs) assume a critical part in many biological roles. Apart from
42
serving as precursors of a wide range of signalling and structural molecules, they are used
43
to obtain energy.2 Although many of the circulating FFAs are bound to albumin, the small
44
fraction of unbound FFAs in the aqueous phase mediate physiological activity and are most
45
sensitive to changes in health and disease; they are also transported across membranes.3
46
Previous data have recognised the importance of certain polyunsaturated FAs (PUFAs)
47
for the prevention of CRC, while the results from epidemiological studies have suggested a
48
negative correlation between both CRC development and PUFA intake.4 Some studies have
49
also found that, in vitro, some PUFAs increase the cytotoxicity of different
50
chemotherapeutics in brain, lung, breast, sarcoma, lymphocytic and colon human cell
51
cultures.5 The degree of in vitro anticancer activity of various FAs has been related to their
52
chemical structure, both of which increase such actions. Montaung et al.6 evaluated the
53
cytotoxic capacity of most of the FAs of interest in a combined manner in prostate cancer
54
cells.
55
n-3 PUFAs have been correlated with CRC preventive effects while n-6 PUFAs have
56
shown a positive association with CRC, although some authors have undermined this
57
archetype by proposing more complex functions for PUFAs.7,8 Because of the nutrition and
3
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
58
health claims made on n-3 PUFAs, they are widely available in a ‘nutraceutical’
59
formulations.9 Although n-6 PUFAs show a positive association with CRC risk,9 some
60
studies have also found that arachidonic acid (ARA, 20:4n6) inhibits the growth of some
61
cancer cell lines, such as Caco-2, but not HT-29.10 In addition, eicosanoids, biologically
62
active molecules derived from ARA, have been proposed as mediators involved in
63
intestinal epithelial homeostasis; other studies have linked hydroxyeicosatetraenoic acids
64
(HETEs), metabolised from ARA by the lipoxygenase (LOX) pathway and cytochrome P-
65
450 isozymes, with cancer-related processes such as cell apoptosis and proliferation,
66
angiogenesis, or metastasis.11-13 But because of the contradictory effects of the
67
manipulation of the ARA cascade,12,14 the mechanisms that mediate these effects remain
68
unclear.
69
Different mechanisms have been suggested to participate in the anticancer activities of
70
n-3 PUFAs, such as apoptosis promotion, inhibition of cell transformation and repression
71
of cell proliferation. Many of them have been associated to the repression of eicosanoids
72
production from n-6 PUFAs.15 Previous studies have tested the inhibition of HT-29 cell
73
proliferation produced by some n-3 FAs. Docosahexaenoic acid (DHA, 22:6n3) strongly
74
and dose-dependently promotes apoptosis, and it enhances many cellular responses that
75
decrease cell proliferation. Because DHA is promptly integrated into cancer cell
76
membranes, considerable research has been conducted on membrane–initiated phenomena.
77
For instance, DHA has been described to take part in the promotion of apoptosis and the
78
inhibition of both in vivo and in vitro proliferation. However, the role of DHA on cell cycle
79
regulation has been scarcely studied on cancer cells, and therefore the mechanisms of
80
action of DHA are not yet entirely understood.16
4
ACS Paragon Plus Environment
Page 4 of 36
Page 5 of 36
Journal of Agricultural and Food Chemistry
81
As for ARA, previous studies have debated whether the increased ARA metabolism
82
found in cancer cells is an initiator or an output of tumour progression. Studies on COX-2
83
and its inhibitors have strongly supported the notion that the induction of COX-2 is a
84
critical step in carcinogenesis and tumour growth. A previous study has also shown that
85
unesterified ARA is an important signal for apoptosis and that the apoptosis promotion by
86
nonsteroidal anti-inflammatory drugs and other inhibitors of ARA metabolism results from
87
ARA accumulation.17. Bishayee and Sethi18 have stated that the ARA pathway, a metabolic
88
process, plays a key role in carcinogenesis. Hence, previous studies have considered the
89
ARA pathway metabolic enzymes phospholipase A2s, cyclooxygenases (COXs) and
90
lipoxygenase (LOX) – together with the metabolic derivatives of these enzymes, such as
91
prostaglandins and leukotrienes – to be new targets for the prevention and treatment of
92
cancer.
93
This work has attempted to determine the in vitro anticancer activities of DHA and
94
ARA, based on the regulation of gene transcription in HT-29 CRC cells. To do so, we
95
performed different cell assays and studied protein abundance changes induced by DHA
96
and ARA in the global proteome of these cells by means of a quantitative proteomics
97
approach based on liquid chromatography–mass spectrometry (LC-MS) called “sequential
98
windowed acquisition of all theoretical fragment ion mass spectra” (SWATH-MS)19
99
followed by pathway analysis.
100 101
MATERIALS AND METHODS
102
Oil Samples
5
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
103
Two commercial oils, DHASCO® and ARASCO®, 40% DHA and 40% ARA,
104
respectively, obtained from the Market Bioscience Corporation (Columbia, MD, USA),
105
were used as a source for obtaining DHA and ARA FFAs. DHASCO® and ARASCO® are
106
produced by combining high oleic sunflower oil with an oil obtained from a unicellular alga
107
(Crypthecodinium cohnii) and a fungi (Mortierella alpina ), respectively.
108
Purification process
109
ARA and DHA as FFAs were purified from 40 mg of DHA- or ARA-ethyl ester
110
according to a previously described chromatography process,20 using mixtures of n-hexane
111
and acetone as eluting solvents in the sequence shown in Supplementary Table S1,
112
optimized for maximizing PUFA purity, and at flow rates of approximately 1–2 mL/min.
113
Eluting fractions were collected in labelled tubes and analysed directly using GLC to
114
determine the purity grade. Subsequently, the ethyl esters were acidified according to
115
Vázquez and Akoh’s approach.21 FFAs were obtained in this manner.
116
GLC analyses
117
A GLC device (Focus, Thermo Electron, Cambridge, UK) combining a flame ionisation
118
detector with a capillary column (30 m x 0.25 mm ID x 0.25 µm) (Omegawax 250, Supelco
119
(Bellefonte, PA, USA)) were used for FA ethyl esters analysis. Temperature of the oven
120
was programmed as follows: 90ºC for 1 min, increase to 100°C in 1 min, then 3 min at
121
100°C, increase of 6ºC/min until reaching 260°C, and finally a step of 260°C during 5 min.
122
The injector temperature was set to 250°C, with a split ratio of 50:1 and an injector volume
123
of 4 µL. The detector temperature was set to 260°C. Nitrogen carrier gas flow was 1
124
mL/min.
6
ACS Paragon Plus Environment
Page 6 of 36
Page 7 of 36
125 126
Journal of Agricultural and Food Chemistry
Cell assays The cell line used for the assays was HT-29 (colon cancer), kindly provided by the
127
Technical Instrumentation Facility of the University of Granada (Granada, Spain), and
128
incubated at 37°C and 5% CO2 in Gibco RPMI 1640 medium 1640 (Thermo Fisher
129
Scientific, Waltham, MA, USA) with penicillin-streptomycin (100 mg/ml), 1-glutamine (2
130
mM), sodium pyruvate (1mM) and 5% foetal bovine serum. Cell cultures and a 3-(4,5-
131
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test were conducted as
132
detailed in previous works.22
133
Final concentration of the purified acyl species (acetone-diluted ARA-FFA or DHA-
134
FFA) added to the medium was in the range of 50–600 µM. The final concentration of
135
acetone added to culture medium, was 1% (v/v). Control cells were also cultured with a
136
medium containing 1% acetone. Lactate dehydrogenase (LDH) assay (the In Vitro
137
Toxicology Assay Kit, Lactic Dehydrogenase base, Sigma TOX 7, Sigma-Aldrich, St.
138
Louis, MO, USA) was conducted as for the MTT assay but with a cell density of 5 ×
139
103 cells/well, and measures were performed following the manufacturer’s instructions. The
140
results were obtained by determining the absorbance at 490 nm with a reference filter at
141
690 nm at 48 h and 72 h. For measuring caspase-3 activity we used the Caspase-3 Assay
142
Kit (Sigma CASP-3-C, Sigma-Aldrich, St. Louis, MO, USA) following the instructions
143
from the manufacturer and determining the absorbance (450 nm) at 90 min, with a cell
144
density of 1 x 107.
145
Proteomics analysis
146
Sample preparation
7
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
147
HT-29 cells from three different groups – DHA (600 µM DHA, added to the culture
148
medium at 24h), ARA (600 µM, added at 24h) and control (no acyl species added) – were
149
recovered and lysed. Protein extracts were obtained from six biological replicates for each
150
group, and protein content was solubilized in 0.2% RapiGest SF (Waters, Milford, MA,
151
USA) after precipitation. Protein content in each sample was determined using a nano-
152
fluorimetric assay (Qubit Protein Assay, Thermo Fisher Scientific). 40 µg of protein was
153
digested with trypsin (Promega, Madison, WI, USA) as previously described23 in two steps,
154
incubating at 37ºC for 2 h in the first step and for 15 h in the second step. RePliCal iRT
155
peptides (PolyQuant GmbH, Bad Abbach, Germany) were spiked into each sample in order
156
to calibrate the peptide retention times in the SWATH runs.
157
Creation of the spectral library
158
For building the spectral library, equal mixtures of the six biological replicates from
159
each condition were pooled and analysed using a shotgun data-dependent acquisition
160
(DDA) approach by nano-liquid chromatography coupled to tandem mass spectrometry
161
(nLC-MS/MS) as described elsewhere24. The equipment used was a Sciex Triple TOF
162
5600+ (Redwood City, CA, USA) coupled to an Eksigent Ekspert nLC415 (Sciex)
163
equippled with a reversed phase capillary column (Acclaim PepMap C18, Thermos Fisher
164
Scientific). Detailed LC and mass spectrometry parameters used can be found in the
165
Supplementary Material.
166
DDA runs were searched against a human Swiss-Prot protein database (20,200 entries,
167
appended with the sequences from the RePliCal iRT peptides) using Protein Pilot (Sciex,
168
version 5.0.1), setting a false discovery rate (FDR) threshold of 0.01. SWATH Acquisition
8
ACS Paragon Plus Environment
Page 8 of 36
Page 9 of 36
Journal of Agricultural and Food Chemistry
169
MicroApp (version 2.0, Sciex) was used for building a peptide spectral library containing
170
the peptides identified in the database search with a confidence score above 99%.
171
SWATH data acquisition and analysis
172
Two µL of each of the six biological replicates from each group was run in the same LC
173
parameters and MS equipment described above for the DDA runs, but using a SWATH
174
data-independent acquisition (DIA) method instead. Mass spectrometry parameters used in
175
the SWATH method are detailed in the Supplementary Material. Briefly, it consisted on the
176
acquisition of 60 MS/MS events with precursor isolation windows of variable width
177
comprising the 350-1,250 m/z range. The width of each of the 60 m/z windows was
178
adjusted according to the ion frequency found in the previous shotgun runs.
179
Protein quantitative data was extracted from the SWATH raw files as previously
180
described24. Briefly, SWATH Acquisition MicroApp was used for extracting the ion
181
chromatogram traces from the SWATH raw files and using the previously generated
182
spectral library, and the following parameters: ten peptides/protein; seven fragment
183
ions/peptide; extraction windows of 20 min and 20 ppm; peptide FDR of 1% and
184
confidence score threshold of 95%. The iRT peptides spiked in each samples were used for
185
realigning the retention times of the quantified peptides.
186
Pathway analysis
187
The significantly affected pathways were studied using Advaita Bio’s iPathwayGuide
188
(http://www.advaitabio.com/ipathwayguide), which considers over-representation of
189
significant proteins, pathway topological information and position and role of every
9
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
190
protein.25 Pathways obtained from the “Kyoto Encyclopedia of Genes and Genomes”
191
(KEGG) database were used.
192
Statistical analysis
193
For cell assays (MTT, LDH and caspase-3 assays), statistical significance (P < 0.05) was
194
determined by analysis of variance (ANOVA) followed by the assessment of differences
195
using STATGRAPHICS Plus version 5 (Statistical Graphic Corp., Warrenton, VA, USA).
196
Figs. 1 and 2 show mean data for three independent experiments ± standard deviation.
197
Normalisation of the protein abundance signal as measured by SWATH was carried out
198
using MarkerView (v1.2.1, Sciex), and testing for differential abundance was performed at
199
the protein level by applying a Student’s t-test. The qvalue R package was used in order to
200
obtain a FDR q-value estimation to check for multiple testing underestimation of p-
201
values26. For pathway analysis, a p-value was calculated for each reported pathway by
202
iPathwayGuide using the Fisher’s method, and p-values were adjusted for multiple
203
comparisons using the FDR approach.
204 205
RESULTS AND DISCUSSION
206
Antiproliferative actions of DHA and ARA
207
The purity of the assayed PUFAs was found to be 98.1% and 99.2% (FA% of total FA
208
area) for DHA and ARA, respectively. The cell proliferation inhibition exercised by both
209
FFAs on HT-29 CRC cells was evaluated by means of the MTT test, which measures cell
210
survival and proliferation. The effects of DHA and ARA on HT-29 cell proliferation are
211
shown in Fig. 1.A. As depicted in the figure, significant concentration-dependent inhibitory
10
ACS Paragon Plus Environment
Page 10 of 36
Page 11 of 36
Journal of Agricultural and Food Chemistry
212
effects were found from the two studied compounds. The half-maximal inhibitory
213
concentrations (IC50) at 48 h and 72 h for DHA were 259 µM and 245 µM, respectively,
214
while for ARA the same values were 368 µM and 324 µM, respectively.
215
For the physiological relevance of these concentrations, a previous study found the
216
serum concentration of DHA in rats to be 97.3 µg/ml (297 µM) after 4 weeks of DHA
217
supplementation.27 The present IC50 for DHA may thus be relevant to tumour progression
218
in vivo, while uncertainty remains for ARA; it would be necessary to experiment in vivo to
219
determine the concentrations of such PUFAs attainable in serum without producing adverse
220
effects.
221
Das and Das,28 using MTT assay, found a significant cell viability reduction of SH-
222
SY5Y (55% reduction) and C6G cells (54% reduction) after a 24 h incubation with 100 µM
223
DHA. In addition, Ramos-Bueno et al.22 demonstrated that acyl-species ARA and DHA
224
derived from ARASCO® and DHASCO® oils, respectively, had relatively high in vitro
225
anticancer activity on HT-29 cells. Chen et al.,29 using the MTT test, showed that Hep G2-
226
MV2E1-9 cells lost more than 80% viability after a pretreatment with 50 µM ARA.
227
LDH assay
228
An LDH assay was conducted to assess the release of the lactate dehydrogenase enzyme
229
into the culture medium after cell membrane damage caused by both DHA and ARA. The
230
concentrations for performing the tests were 0–600 µM, at which the tested compounds
231
showed different in vitro antiproliferative activities from those detected by the MTT assay.
232
DHA induced more active damage at 300 µM and 48 h exposure than ARA did (Fig.
233
1.B), although at 500 µM and after 72 h exposure, ARA was more effective in this action
11
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
234
than DHA. Overall, LDH values were lower than those obtained in the MTT assay. In this
235
regard, Ramos-Bueno et al.22 indicated that, when comparing the effects measured by LDH
236
and MTT assays, the former were attained at higher levels of cell damage. Such differences
237
could be attributable to the specificity of LDH testing compared to the MTT assay. A
238
previous study showed that LDH leakage occurred only when reactive oxygen species
239
related to cell death appeared, which were responsible for mitochondrial damage.22 Overall,
240
the MTT assay showed cell growth inhibition at lower concentrations of FFA than the LDH
241
test, because MTT reduction is not an indicator of cell death but rather constitutes a
242
measure of relative metabolic activity, as demonstrated in a previous study on HT-29
243
cells.30 Concerning ARA, our results agree with previous findings,29,31 which have shown
244
the same PUFA-stimulated LDH activity in some other cells (e.g. Hep G2-MV2E1-9 and
245
Sertoli).
246
Caspase-3 assay
247
The activation of caspase-3, specifically through self-cleavage, has been shown to be the
248
event that commits cells to apoptotic death.32 As shown in Fig. 2, DHA induced caspase-3
249
activation at 300 µM, while ARA did not, and both PUFAs exercised a similar induction of
250
apoptosis at 600 µM. Several studies have suggested that DHA displays a notable
251
protective effect on CRC, which could be at least partly due to its pro-apoptotic activity.
252
The mechanisms affected by DHA for promoting apoptosis in CRC are still largely
253
unknown, however. Previous works have demonstrated the apoptotic activity exerted by
254
DHA in several cancer cell lines,33,34 while a variety of authors have tested whether DHA
255
induced apoptosis in CRC cells.4,35,36. Habermann et al.,37 using an in vitro model and HT-
256
29 and LT97 cells, proposed a generic mechanism for the apoptosis promoted by DHA that
12
ACS Paragon Plus Environment
Page 12 of 36
Page 13 of 36
Journal of Agricultural and Food Chemistry
257
was based on inducing reactive oxygen species due to DHA double bonds, which led to
258
apoptosis. Narayanan et al.38 found that DHA-regulated genes and transcription factors
259
induced apoptosis in human colon cancer cells. Zhang et al.39 have also proposed that both
260
DHA and ARA trigger the apoptosis of colon cancer cells through a mitochondrial
261
pathway; they found that DHA in particular induced dramatic activities in both caspase-3
262
and caspase-9.
263
Proteomics analysis
264
DIA MS strategies are showing great power for the study of abundance differences in
265
complete proteomes. Precision and accuracy of the DIA approach of SWATH-MS19 has
266
been described to match that of selected reaction monitoring, the gold standard in protein
267
quantitation, even when applied to the quantitation of whole proteomes.40
268
Shotgun analysis and spectral library
269
Equal amounts of all samples from each group were pooled and analysed by DDA LC-
270
MS. All the datasets were combined, and 15,406 peptides and 2,140 proteins were
271
identified using the ProteinPilot search engine using a FDR threshold of 1%
272
(Supplementary Table S2). This search result was then used for building a spectral library,
273
which comprised 2,002 proteins.
274
Protein abundance changes
275
Protein quantitative data was extracted from the SWATH raw files as described in
276
Material and Method above. In total, 7,653 peptides and 1,882 proteins were confidently
277
quantified (Supplementary Table S3). To assess the global impact of the overall quantified
278
proteins, principal component analysis (PCA) was performed on the whole protein dataset.
13
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
279
PCA was able to separate the two tested groups from each other and from the control group
280
(Fig. 3a), thus showing a large and different effect of the specific FFA (DHA or ARA) on
281
HT-29 colon cancer cell proteomes.
282
Effects of DHA and ARA on HT-29 colon cancer cell proteomes
283
Supplementary Tables S4 and S5 show the results from the differential abundance
284
testing for both comparisons (the DHA group to control and the ARA group to control,
285
respectively), including a p-value and the corresponding FDR-adjusted q-value for each of
286
the 1,882 quantified proteins. A total of 1,015 proteins showed changes in expression when
287
we addressed the impact of the DHA extract and considered a non-adjusted p-value
288
threshold of 0.05. Notably, due to the p-value distribution (Supplementary Fig. S1a), the q-
289
values obtained from the FDR p-value correction were lower than the corresponding non-
290
adjusted p-values (Supplementary Fig. S1b), which meant that we had more significant
291
tests (significant proteins) if we chose a q-value threshold rather than a p-value threshold in
292
order to consider a protein to be significantly regulated (Supplementary Fig. S1c).
293
For downstream analyses, we considered a restrictive scenario – namely p-value and
294
fold-change thresholds of 0.01 and 2.0, respectively – in order to have more confidence in
295
selecting the proteins that presented real expression changes. When we applied these cut-
296
off values, 284 proteins showed changes in expression, with 45 proteins being up-regulated
297
and 239 down-regulated (Fig. 3b and Supplementary Fig. S6).
298
When we addressed the changes caused by the ARA extract on HT-29 cancer cells and
299
applied the same p-value and fold-change cut-off values, only 73 proteins were found to
300
present changes in expression, with 27 proteins being up-regulated and 46 down-regulated
301
(Fig. 3c and Supplementary Fig. S7). The p-value distribution, q-value to p-value
14
ACS Paragon Plus Environment
Page 14 of 36
Page 15 of 36
Journal of Agricultural and Food Chemistry
302
correspondence, and number of significant proteins according to several cut-off values for
303
ARA to control differential abundance tests are shown in Supplementary Fig. S2. When we
304
compared the 284 and 73 proteins that we found were regulated as a consequence of adding
305
DHA and ARA to the media (respectively), only 43 proteins were commonly regulated in
306
both conditions (Fig. 3d). DHA was responsible for a larger effect on HT-29 cancer cells
307
than ARA, as it is derived from the number of affected proteins and the larger fold changes
308
that are found.
309
Pathway impact analysis
310
After FDR correction of the p-values, three pathways were found to be significantly
311
affected by DHA (Fig. 4), with the Proteasome pathway (KEGG: 03050) presenting the
312
deepest effect. The proteasome is a protein-degrading large complex which participates in
313
different critical cellular functions, including cell cycle regulation, inflammatory and stress
314
responses, apoptosis, signal transduction, cell differentiation and antigen processing. The
315
26S proteasome is the most characteristic conformation, consisting of two 19S regulatory
316
particles (which combine two base particles, PA700 Lid and PA700 Base) and a 20S
317
proteolytic particle, and it is responsible for the degradation of ubiquitinated-labelled
318
proteins.41 The 11S Regulator particle, or PA28, is a second type of proteasome particle. It
319
consists of two different subparticles, PA28-α and PA28-β, which have been described to
320
be greatly up-regulated by IFN-γ and have a role in generating antigenic peptides that are
321
presented in the MHC-I pathway.42 We found up to 18 proteins from the Proteasome
322
pathway to be down-regulated as a consequence of the addition of DHA extract, including
323
members of most of the proteasome regulatory particles (PA700 Lid particle, PA700 Base
324
particle, PA28-αβ and PA28-γ), in addition to the 20S Core particle (Fig. 5). PA28- γ is
15
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
325
localised in the nucleus and has been described to have a role in apoptosis and cell cycle
326
regulation.43 Many proteasome inhibitors, including natural substances such as polyphenol
327
compounds, have been found to hinder cell proliferation, selectively promote apoptosis in
328
proliferating cells, and inhibit angiogenesis.44,45 These qualities make these agents attractive
329
drug candidates for treating different kinds of cancer, and some have even been studied in
330
human clinical trials.44,46 According to our results, DHA-derived FFA could be included
331
among these candidates. Even though the mechanisms of action are not completely
332
understood, various studies have demonstrated that proteasome inhibitors alter the balance
333
of pro- and anti-apoptotic proteins in human cancer cells, generating an accumulation of
334
tumour-suppressor proteins and the induction of apoptosis.47 Some authors have suggested
335
that proteasome inhibitors promote cell death by means of a p53-dependent mechanism, by
336
inducing the expression of some of the genes related to apoptosis, such as PUMA or Bax.48
337
Others, however, have pointed to a p53-independent mechanism of proteasome inhibitors-
338
induced apoptosis. Noxa, one pro-apoptotic protein, has been linked to this apoptosis
339
mechanism, since several proteasome inhibitors have been found to induce it in a p53-
340
independent manner in cancer cells of different origins.49 Our data could not clearly
341
demonstrate a p53-dependent nor independent mechanism of apoptosis. No quantitative
342
information was obtained from our SWATH-MS analysis for the main pro- and anti-
343
apoptotic proteins, PUMA, NOXA, Mcl-1, p21 or Bcl-2. A few other pro-apoptotic factors
344
and tumour-suppressor proteins were found to be slightly up-regulated, such as AIFM1
345
(apoptosis-inducing factor 1, fold-change 1.65) and P5i11 (tumour protein p53-inducible
346
protein 11, fold-change 1.40). A few other anti-apoptotic proteins were found to be down-
347
regulated, including API5 (apoptosis inhibitor 5, fold-change 0.70), which has been
348
described as a suppressor of E2-promoter binding factor-dependent apoptosis in vivo and in 16
ACS Paragon Plus Environment
Page 16 of 36
Page 17 of 36
Journal of Agricultural and Food Chemistry
349
vitro in multiple tissues,50 and TNF-α induced protein 8 (TFIP8, fold-change 0.61), which
350
is an inhibitor of TNF-mediated apoptosis.51
351
Notably, we found PAWR (PRKC apoptosis WT1 regulator protein), a protein described
352
as pro-apoptotic in certain cancer cells such as prostate,52 to be down-regulated as an effect
353
of the DHA treatment on HT-29 cells (fold-change 0.52). But when we analysed the
354
differentially expressed proteins in the context of the p53 signalling pathway in
355
iPathwayGuide, we found that three key proteins were regulated by DHA (Supplementary
356
Fig. S3): TSP1 (thrombospondin 1, gene THBS1), which mediates anti-angiogenic
357
properties, presented a fold-change of 2.05; CDC2 (gene CDK1, cyclin dependent kinase
358
1), which regulates cell cycle and whose inhibitors are being explored as chemotherapeutic
359
agents in cancer,53 presented a fold-change of 0.24; and p53R2 (RIR2, ribonucleotide
360
reductase regulatory subunit M2, gene RRM2), involved in DNA synthesis, presented a
361
fold-change of 0.33. Interestingly, none of the proteins related to apoptosis within the p53
362
signalling pathway were affected by DHA (Supplementary Fig. S3). This behaviour could
363
point to a p53-independent mechanism of apoptosis as a consequence of treating HT-29
364
cells with DHA, although more research would be required to maintain this argument.
365
When we added ARA-FFA to the HT-29 cells, only one protein in the p53 signalling
366
pathway, p53R2 (gene RRM2), resulted in regulation (down-regulation).
367
According to our pathway analysis, two other pathways, Epstein Barr virus (EBV)
368
infection (KEGG: 05169) and DNA replication (KEGG: 03030), were also found to be
369
significantly affected by the addition of DHA, although the effect was not as evident as for
370
the Proteasome pathway, which presented much higher p-values. EBV is a ubiquitous
371
human herpesvirus that has been associated with oncogenesis in Burkitt lymphoma,
17
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
372
nasopharyngeal carcinoma, Hodgkin’s lymphoma, gastric adenocarcinoma and breast
373
cancer.54 Sixteen proteins from the EBV infection pathway were affected by DHA in our
374
study, with 14 proteins down-regulated, most related to DNA transcription factors
375
(Supplementary Fig. S4a). EBV makes cancer cells more aggressive,54 so we hypothesise
376
that the down-regulation of the proteins related to this pathway (which we found as a
377
consequence of adding DHA) could have had the opposite effect – that is, reducing
378
colorectal cancer cell viability. For DNA replication, DHA was found to produce the under-
379
expression of five out of the six helicase (also called the mini-chromosome maintenance
380
[MCM] complex) particles: Mcm2, Mcm3, Mcm4, Mcm5 and Mcm7 (Supplementary Fig.
381
S4b).
382
DNA replication was the top-ranked pathway when assessing the effect of ARA extract;
383
in that case, all six helicase particles (Mcm2, Mcm3, Mcm4, Mcm5, Mcm6 and Mcm7)
384
were found to be down-regulated (Fig. 6), presenting larger fold-changes than for DHA.
385
DNA helicase is the protein complex that unwinds the duplex parental DNA at the
386
replication fork, ahead of the DNA synthetic machinery.55 DNA replication procedure is
387
likewise linked to cell-cycle and to DNA processes in order to support genomic integrity,56
388
and therefore the down-regulation of the helicase proteins that our results showed was
389
expected to transfer an inhibitory effect to these processes. In fact, the Cell Cycle pathway
390
(KEGG: 04110) – which also occurred due to the down-regulation of the six MCM
391
particles – and the Pyrimidine Metabolism (KEGG: 00240) pathway were the two other
392
significant pathways affected by the addition of ARA (Supplementary Fig. S5), although
393
the Pyrimidine Metabolism pathway presented a much higher p-value than the DNA
394
replication and Cell Cycle pathways. Interestingly, neither the Proteasome pathway nor the
18
ACS Paragon Plus Environment
Page 18 of 36
Page 19 of 36
Journal of Agricultural and Food Chemistry
395
EBV pathway were significantly affected by ARA, since none of the proteins included in
396
these pathways were found to have been differentially expressed.
397
We have established that both ARA-FFA and DHA-FFA exercise different in vitro
398
anticancer activities on CRC. At 300 µM, DHA induced a stronger decrease of colorectal
399
cancer cell proliferation than ARA did, but DHA also induced fewer cytotoxic effects.
400
Pathway analyses of the SWATH-MS-generated proteomics data revealed that both FAs
401
had an impact on the cell cycle by means of down-regulating the protein particles that form
402
the helicase complex, but DHA also affected the proteasome system, since many proteins
403
from the different proteasome subunits were also under-expressed.
404
The present study shows that DHA and ARA are significantly inhibiting the growth of
405
cancer HT-29 cells depending on time and concentration, which suggests that both of them
406
may be helpful for hindering the development of aggressive adenocarcinoma.
407
Based on these findings, further studies will need to be conducted to determine if
408
a combination of PUFAs with regular anticancer molecules would represent a reasonable
409
approach to CRC treatment. The use of next-generation proteomics and other ‘omics’
410
approaches will allow for analysing the effects of natural compounds on global patterns of
411
gene expression and protein composition of the cell, thus improving the knowledge that we
412
have about the biological roles of nutraceuticals.
413 414 415 416
Supporting Information description The LC-MS raw files associated with this article are available at www.proteomexchange.org (Proteome Xchange Consortium), dataset id PXD008653. The
19
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
417
following supporting information and material can be found in the Web edition of the
418
Journal:
419
Supplementary material.pdf, including the detailed LC and mass spectrometry parameters
420
used for both data-dependent acquisition and SWATH methods, and figures S1
421
(Differential abundance test results for DHA vs. control), S2 (Differential abundance test
422
results for ARA vs. control), S3 (HT-29 cells p53 signaling pathway showing protein
423
changes observed as a result of treatment with DHA), S4 (HT-29 cells Epstein Barr virus
424
infection and DNA replication pathways showing the effect of DHA treatment), and S5
425
(HT-29 cells cell cycle and pyrimidine metabolism pathways showing the effect of ARA
426
treatment), and Table S1 (gradient used in the chromatographic purification of both free
427
fatty acids, DHA and ARA).
428
Supplementary Table S2.xlsx. 2,140 proteins that were identified using the ProteinPilot
429
search engine and a FDR threshold of 1%.
430
Supplementary Table S3.xlsx. SWATH-based protein quantification data for all the
431
samples.
432
Supplementary Table S4.xlsx. Differential abundance test for DHA vs. control.
433
Supplementary Table S5.xlsx. Differential abundance test for ARA vs. control.
434
Supplementary Table S6.xlsx. Differential expressed proteins for DHA vs. control.
435
Supplementary Table S7.xlsx. Differential expressed proteins for ARA vs. control.
436 437
References
20
ACS Paragon Plus Environment
Page 20 of 36
Page 21 of 36
438
Journal of Agricultural and Food Chemistry
1. Azrad, M.; Turgeon, C.; Demark-Wahnefried, W. Current evidence linking
439
polyunsaturated fatty acids with cancer risk and progression. Front. Oncol. 2013,
440
3,224.
441
2. Hardy, S.; El-Assaad, W.; Przybytkowski, E.; Joly, E.; Prentki, M.; Langelier, Y.
442
Saturated Fatty Acid-induced Apoptosis in MDA-MB-231 Breast Cancer Cells. J. Biol.
443
Chem. 2003, 278, 31861-31870.
444
3. Kampf, J.P.; Kleinfeld, A.M. Is membrane transport of FFA mediated by lipid, protein,
445
or both? An unknown protein mediates free fatty acid transport across the adipocyte
446
plasma membrane. Physiology (Bethesda) 2007, 22, 7-14.
447
4. Calviello, G.; Resci, F.; Serini, S.; Piccioni, E.; Toesca, A.; Boninsegna, A.; Monego, G.;
448
Ranelletti, F.; Palozza. P. Docosahexaenoic acid induces proteasome-dependent
449
degradation of b-catenin, down-regulation of survivin and apoptosis in human
450
colorectal cancer cells not expressing COX-2. Carcinogenesis 2007, 28, 1202–1209.
451
5. Antal, O.; Hackler,L.; Shen, J.; Mán, I.; Hideghéty, K.; Kitajka, K.; Puskás, L.G.
452
Combination of unsaturated fatty acids and ionizing radiation on human glioma cells:
453
cellular, biochemical and gene expression analysis. Lipids Health Dis. 2014, 13, 142.
454
6. Motaung, E.; Prinsloo, S. E.; van Aswegen, C. H.; du Toit, P. J.; Becker, P. J.; du Plessis,
455
D. J. Cytotoxicity of combined essential fatty acids on a human prostate cancer cell
456
line. Prostaglandins, Leukotrienes Essent. Fatty Acids 1999, 61, 331-337.
457
7. Zhang, C.; Yu, H.; Ni, X.; Shen, S.; Das, U.N. Growth Inhibitory Effect of
458
Polyunsaturated Fatty Acids (PUFAs) on Colon Cancer Cells via Their Growth
459
Inhibitory Metabolites and Fatty Acid Composition Changes. PLoS ONE 2015, 10,
460
e0123256.
21
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
461
8. Michalak, A.; Mosinska, P.; Fichna, J. Polyunsaturated Fatty Acids and Their
462
Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal
463
Disorders, and Colorectal Cancer. Front. Pharmacol. 2016, 7, 459.
464 465
9. Cockbain, A.J.; Toogood, G.J.; Hull, M.A. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012, 61, 135-149.
466
10. Dommels, Y. E.; Haring, M. M.; Keestra, N. G.; Alink, G. M.; van Bladeren, P. J.; van
467
Ommen, B. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid
468
mediated effects on cell proliferation, PGE 2 synthesis and cytotoxicity in human
469
colorectal carcinoma cell lines. Carcinogenesis 2003, 24, 385-392.
470 471 472 473 474 475 476 477
11. Moreno, J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem. Pharmacol. 2009, 77, 1-10. 12. Ferrer, R.; Moreno, J.J. Role of eicosanoids on intestinal epithelial homeostasis. Biochem. Pharmacol. 2010, 80, 431-438. 13. Moreno, J.J. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis. Eur. J. Pharmacol. 2017, 796, 7-19. 14. Cabral, M.; Martin-Venegas, R.; Moreno, J.J. Leukotriene D4-induced Caco-2 cell proliferation is mediated by prostaglandin E2 synthesis. Physiol. Rep. 2015, 3, e12417.
478
15. Kang, K.S.; Wang, P.; Yamabe, N.; Fukui, M.; Jay, T.; Zhu, B.T. Docosahexaenoic
479
Acid Induces Apoptosis in MCF-7 Cells In Vitro and In Vivo via Reactive Oxygen
480
Species Formation and Caspase 8 Activation. PLoS ONE 2010, 5, e10296.
481
16. Newell, M.; Baker, K.; Postovit, L.M.; Field, C.J. A Critical Review on the Effect of
482
Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression. Int. J. Mol. Sci.
483
2017, 18, 1784.
22
ACS Paragon Plus Environment
Page 22 of 36
Page 23 of 36
484
Journal of Agricultural and Food Chemistry
17. Cao, Y.; Pearman, A. T.; Zimmerman, G. A.; McIntyre, T. M.; Prescott, S. M.
485
Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl. Acad. Sci. U.
486
S. A. 2000, 97, 11280-11285.
487 488 489
18. Bishayee, A.; Sethi, G. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin. Cancer Biol. 2016, 40-41, 1-3. 19. Gillet, L.C.; Navarro, P.; Tate, S.; Röst, H.; Selevsek, N.; Reiter, L.; Bonner, R.;
490
Aebersold, R. Targeted data extraction of the MS/MS spectra generated by data-
491
independent acquisition: a new concept for consistent and accurate proteome analysis.
492
Mol. Cell. Proteomics 2012, 11, O111.016717.
493
20. Guil-Guerrero, J.L.; Campra-Madrid, P.; Belarbi, E.H. (2000). γ-Linolenic acid
494
purification from seed oil sources by argentated silica gel chromatography column.
495
Process Biochem. 2000, 36, 341-354.
496
21. Vázquez, L.; Akoh, C.C. Concentration of Stearidonic Acid in Free Fatty Acid and
497
Fatty Acid Ethyl Ester Forms from Modified Soybean Oil by Winterization. J. Am. Oil
498
Chem. Soc. 2011, 88, 1775-1785.
499
22. Ramos-Bueno, R.P.; González-Fernández, M.J.; Guil-Guerrero, J.L. Various
500
acylglycerols from common oils exert different antitumor activities on colorectal
501
cancer cells. Nutr. Cancer 2016, 68, 518-529.
502
23. Vowinckel, J.; Capuano, F.; Campbell, K., Deery, M. J.; Lilley, K. S.; Ralser, M. The
503
beauty of being (label)-free: sample preparation methods for SWATH-MS and next-
504
generation targeted proteomics. F1000Research 2014, 2, 272.
23
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
505
24. Ortea, I.; Ruiz-Sánchez, I.; Cañete, R.; Caballero-Villarraso, J.; Cañete M. D.
506
Identification of candidate serum biomarkers of childhood-onset growth hormone
507
deficiency using SWATH-MS and feature selection. J. Proteomics 2018, 175, 105-113.
508
25. Tarca, A. L.; Draghici, S.; Khatri, P.; Hassan, S. S.; Mittal, P.; Kim, J. S.; Kim, C. J.;
509
Kusanovic, J. P.; Romero, R. A novel signaling pathway impact analysis.
510
Bioinformatics 2009, 25, 75-82.
511
26. Storey, J. D. Bass, A. J.; Dabney, A.; Robinson D. (2015). qvalue: Q-value estimation
512
for false discovery rate control. R package version 2.10.0.
513
http://github.com/jdstorey/qvalue (accessed at Feb 2018).
514
27. Mizota, A.; Sato, E.; Taniai, M.; Adachi-Usami, E.; Nishikawa, M. Protective effects of
515
dietary docosahexaenoic acid against kainate-induced retinal degeneration in rats.
516
Invest. Ophthalmol. Vis. Sci. 2001, 42, 216-221.
517
28. Das, M.; Das, S. Identification of cytotoxic mediators and their putative role in the
518
signaling pathways during docosahexaenoic acid (DHA)-induced apoptosis of cancer
519
cells. Apoptosis 2016, 21, 1408-1421.
520
29. Chen, Q.; Galleano, M.; Cederbaum, A. I. Cytotoxicity and Apoptosis Produced by
521
Arachidonic Acid in Hep G2 Cells Overexpressing Human Cytochrome P4502E1. J.
522
Biol. Chem. 1997,272, 14532–14541.
523
30. Fotakis, G.; Timbrell, J.A. In vitro cytotoxicity assays: Comparison of LDH, neutral
524
red, MTT and protein assay in hepatoma cell lines following exposure to cadmium
525
chloride. Toxicol. Lett. 2006, 160, 171-177.
526
31. Meroni, S.B.; Riera, M.F.; Pellizzari, E.H.; Shteingart, H.F.; Cigorraga, S.B. Possible
527
role of arachidonic acid in the regulation of lactate production in rat Sertoli cells. Int. J.
528
Androl. 2003, 26, 310-317. 24
ACS Paragon Plus Environment
Page 24 of 36
Page 25 of 36
529
Journal of Agricultural and Food Chemistry
32. Akbar, M.; Kim, H. Y. Protective effects of docosahexaenoic acid in staurosporine-
530
induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J.
531
Neurochem. 2002, 82, 655-665.
532
33. Chen, Z. Y.; Istfan, N. W. Docosahexaenoic acid is a potent inducer of apoptosis in HT-
533
29 colon cancer cells. Prostaglandins, Leukotrienes Essent. Fatty Acids 2000, 63, 301-
534
308.
535
34. Giros, A.; Grzybowski, M.; Sohn, V. R.; Pons, E.; Fernandez-Morales, J.; Xicola, R.
536
M.; Sethi, P.; et al. Regulation of colorectal cancer cell apoptosis by the n-3
537
polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev. Res.
538
2009, 2, 732-742.
539
35. Kato, T.; Kolenic, N.; Pardini, R. S. Docosahexaenoic acid (DHA), a primary tumor
540
suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of
541
p53 mutational status. Nutr. Cancer 2007, 58, 178-187.
542
36. Fasano, E.; Serini, S.; Piccioni, E.; Toesca, A.; Monego, G.; Cittadini, A.R.; Ranelletti,
543
F.O.; Calviello, G. DHA induces apoptosis by altering the expression and cellular
544
location of GRP78 in colon cancer cell lines. Biochim. Biophys. Acta 2012, 1822,
545
1762–1772.
546
37. Habermann, N.; Schön, A.; Lund, E.K.; Glei, M. Fish fatty acids alter markers of
547
apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption
548
has no impact on apoptosis-induction ex vivo. Apoptosis 2010, 15, 621-630.
549
38. Narayanan, A.B.; Narayanan, N.K.; Reddy, B.S. Docosahexaenoic acid regulated genes
550
and transcription factors inducing apoptosis in human colon cancer cells. Int. J. Oncol.
551
2001, 19, 1255-1262.
25
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
552
39. Zhang, Ch.; Yu. H.; Shen, Y.; Ni, X.; Shen, S.; Das, U.N. Polyunsaturated fatty acids
553
trigger apoptosis of colon cancer cells through a mitochondrial pathway. Arch. Med.
554
Sci. 2014, 5, 1081-1094.
555
40. Huang, Q.; Yang, L.; Luo, J.; Guo, L.; Wang, Z.; Yang, X.; Jin, W.; Famg, Y.; Ye, J.;
556
Shan, B.; Zhang, Y. SWATH enables precise label-free quantification on proteome
557
scale. Proteomics 2015,15, 1215-1223.
558
41. Adams, G. M.; Falke, S.; Goldberg, A. L.; Slaughter, C. A.; DeMartino, G. N.; Gogol,
559
E. P. Structural and functional effects of PA700 and modulator protein on proteasomes.
560
J. Mol. Biol. 1997,273, 646-657.
561 562 563 564 565 566 567
42. Rechsteiner, M.; Realini, C.; Ustrell, V. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J. 2000, 345, 1-15. 43. Rechsteiner, M.; Hill, C. P. Mobilizing the proteolytic machine: cell biological roles of preoasome activators and inhibitors. Trends Cell Biol. 2005, 15, 27-33. 44. Kisselev, A. F.; Goldberg, A. L. Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 2001, 8, 739-758. 45. Nam, S.; Smith, D.M.; Dou, Q. P. Ester bound-containing tea polyphenols potently
568
inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 2001, 276, 13322-
569
13330.
570 571 572 573
46. Adams, J.; Elliot, P. J. New agents in cancer clinical trials. Oncogene 2000, 19, 66876692. 47. Crawford, L.J.; Walker, B.; Irvine, A.E. Proteasome inhibitors in cancer therapy. J. Cell Commun. Signal. 2011, 5, 101–110.
26
ACS Paragon Plus Environment
Page 26 of 36
Page 27 of 36
574
Journal of Agricultural and Food Chemistry
48. Hock, A.K.; Vigneron, A.M.; Carter, S.; Ludwig, R.L.; Vousden, K.H. Regulation of
575
p53 stability and function by the deubiquitinating enzyme USP42. EMBO J. 2011, 30,
576
4921–4930.
577 578
49. Pandit, B.; Gartel, A.L. Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer Cells. Am. J. Pathol. 2011, 178, 355–360.
579
50. Morris, E.J.; Michaud, W.A.; Ji, J.Y.; Moon, N.S.; Rocco, J.W.; Dyson, N.J. Functional
580
identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet.
581
2006, 2(11), e196.
582
51. You, Z.; Ouyang, H.; Lopatin, D.; Polver, P.J.; Wang, C.Y. Nuclear factor-kappa B-
583
inducible death effector domain-containing protein suppresses tumor necrosis factor-
584
mediated apoptosis by inhibiting caspase-8 activity. J. Biol. Chem. 2001, 276, 26398-
585
26404.
586
52. Chakraborty, M.; Qiu, S.G.; Vasudevan, K.M.; Rangnekar, V.M. Par-4 drives
587
trafficking and activation of Fas and FasI to induce prostate cancer cell apoptosis and
588
tumor regression. Cancer Res. 2011, 61, 7255-7263.
589 590 591
53. Wang, Q.; Su, L.; Liu N.; Zhang, L.; Xu, W.; Fang, H. Cyclin dependent kinase 1 inhibitors: a review of recent progress. Curr. Med. Chem. 2011, 18, 2025-2043. 54. Hu, H.; Luo, M.-L.; Desmedt, C.; Nabavi, S.; Yadegarynia, S.; Hong, A.;
592
Konstantinopoulos, P.A.; et al. Epstein-Barr virus infection of mammary epithelial
593
cells promotes malignant transformation. EBioMedicine 2016, 9, 148-160.
594
55. Stillman, B. Smart machines at the DNA replication fork. Cell, 78, 725-728.
595
56. Waga, S.; Stillman, B. The DNA replication fork in eukaryotic cells. Annu. Rev.
596
Biochem. 1998, 67, 721-751.
597 27
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
598 599
Funding sources Mass spectrometry analyses were performed at the IMIBIC Proteomics Unit, member
600
of ProteoRed (Plataforma de Recursos Biomoleculares y Bioinformáticos) and supported
601
by grant PT13/0001, funded by Instituto de Salud Carlos III (ISCIII) and FEDER.
602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617
28
ACS Paragon Plus Environment
Page 28 of 36
Page 29 of 36
618
Journal of Agricultural and Food Chemistry
FIGURE CAPTIONS
619
Figure 1. Effect of DHA (92.1%) and ARA (98.8%) on proliferation and cell membrane
620
integrity of HT-29 cancer cells treated with 1% acetone (control) or different concentrations
621
of FFAs (50, 100, 150, 250, 300, 500 and 600 µM) for 48 h and 72 h. The data represent
622
the means of three complete independent experiments ± SD (error bars). (a) DHA and
623
ARA-FFAs inhibit the viability of HT-29 cancer cells. Dose-response and IC50 values were
624
determined by MTT assay using an enzyme-linked immunosorbent assay (ELISA)
625
microplate reader. (b) Cell membrane damage; dose-dependent LDH activity plot.
626
Figure 2. Caspase-3 activity test. Bar histogram displaying caspase-3 activity in HT-29
627
colon cancer cells after 90 min incubation with DHA and ARA at 300 and 600 µM,
628
compared with untreated cells (control). The data represent the means of three complete
629
independent experiments ± SD (error bars).
630
Figure 3. Quantitative proteomics results. (a) Principal component analysis (PCA) of all
631
1,882 quantified proteins. Using principal components 1 and 2, samples from the two tested
632
groups were separated from each other and from the control group. (b) Volcano plot for
633
DHA vs control, and (c) ARA vs control, showing p-value < 0.01 and fold-change ≥ 2.0 (or
634
≤ 0.5) thresholds. Proteins above these cut-offs are shown in red and were considered
635
significant proteins for the subsequent downstream analyses. The most extreme proteins are
636
labelled with the protein name. (d) Venn diagram showing the number of significant
637
proteins specifically for each comparison and common to both comparisons.
638
Figure 4. Pathway impact analysis. Pathways with significant impacts and their
639
associated corrected p-values for the differentially expressed proteins for the comparisons
640
of DHA vs control and ARA vs control.
29
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
641
Figure 5. Effect of DHA extract on HT-29 cancer cell Proteasome pathway (KEGG:
642
03050). (a) Proteasome pathway diagram overlaid with the gene’s measured fold change.
643
(b) Gene perturbation bar plot for the Proteasome pathway; differentially expressed genes
644
are represented with negative values in blue; positive values are in red.
645
Figure 6. Effect of ARA extract on HT-29 cancer cell DNA replication pathway
646
(KEGG: 03030). (a) DNA replication pathway diagram overlaid with the gene’s measured
647
fold change. (b) Gene perturbation bar plot for the DNA replication pathway; differentially
648
expressed genes are represented with negative values in blue; positive values are in red.
649 650 651 652 653 654 655 656 657 658 659 660 661 30
ACS Paragon Plus Environment
Page 30 of 36
Page 31 of 36
662
Journal of Agricultural and Food Chemistry
Figure 1.
663
664 665 666
Figure 2.
667 668 669
31
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
670
Figure 3.
671 672
32
ACS Paragon Plus Environment
Page 32 of 36
Page 33 of 36
673
Journal of Agricultural and Food Chemistry
Figure 4.
674 675 676 677 678 679 680 681 682 683 684 685 686 687 688
33
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
689
Figure 5.
690 691 692 693 694 695
34
ACS Paragon Plus Environment
Page 34 of 36
Page 35 of 36
696
Journal of Agricultural and Food Chemistry
Figure 6.
697 698 699 700 701 702 703 704 705 706
35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
707
Graphic for table of contents
708 709
710 711 712 713 714 715 716 717 718 719 720 36
ACS Paragon Plus Environment
Page 36 of 36